Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04146584 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

A Phase 2 study, sponsored by Sofwave Medical.

Completed
Registry status
Phase 2
Development phase
93
Enrollment target

NCT04146584 is a Phase 2 study that has completed, run by Sofwave Medical. The registered enrollment target is 93 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04146584, a Phase 2 study, has completed, sponsored by Sofwave Medical.

COMPLETED
Registry status
Phase 2
Development phase
93 participants
Enrollment target

Study Summary

This is a prospective, open label, multi-center, self-controlled clinical study to demonstrate the safety and efficacy of SofWave treatment to lift lax tissue in the submental and neck zones and to lift the eyebrow.

Interventions

  • DEVICE Sofwave Treatments

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2019-11-20
Est. Completion 2021-03-30
Phase Phase 2

Sponsor

Sofwave Medical

12 total trials

What the Registry Record Tells You About NCT04146584

The ClinicalTrials.gov registry entry for NCT04146584 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sofwave Medical, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Sofwave Treatments is the first listed.

NCT04146584 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04146584 about?

NCT04146584 is a clinical study titled "Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow". This is a prospective, open label, multi-center, self-controlled clinical study to demonstrate the safety and efficacy of SofWave treatment to lift lax tissue in the submental and neck zones and to lift the eyebrow.

What is the current status of trial NCT04146584?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 93 participants. The study started on 2019-11-20. Estimated completion is 2021-03-30.

What interventions are being tested in trial NCT04146584?

The interventions under investigation include: Sofwave Treatments (DEVICE).

Who is sponsoring clinical trial NCT04146584?

This trial is sponsored by Sofwave Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.